Teva To Divest Women's Health, Some Oncology As CEO Search Proceeds
Executive Summary
The company is pursuing the sale of global women's health and its oncology and pain businesses in Europe, Interim CEO Yitzhak Peterburg said during the firm's first quarter earnings call.
You may also be interested in...
Teva Offloads Women's Health Business To Two Firms For $1.38Bn
The generic drug maker signed two deals to divest its women's health business, one with the equity investment firm CVC Capital Partners and the other with Foundation Consumer Healthcare.
Teva Offloads Women's Health Business To Two Firms For $1.38Bn
The generic drug maker signed two deals to divest its women's health business, one with the equity investment firm CVC Capital Partners and the other with Foundation Consumer Healthcare.
Teva SOS: Troubled Drug Maker Seeks Audacious Captain To Take The Wheel
Teva investors have moved beyond restless to the point of jumping ship as the company's generic drug business continues to underperform, with little guidance on plans for a turnaround.